540 related articles for article (PubMed ID: 25220861)
1. Clinical outcomes and genome-wide association for a brain methylation site in an antidepressant pharmacogenetics study in Mexican Americans.
Wong ML; Dong C; Flores DL; Ehrhart-Bornstein M; Bornstein S; Arcos-Burgos M; Licinio J
Am J Psychiatry; 2014 Dec; 171(12):1297-309. PubMed ID: 25220861
[TBL] [Abstract][Full Text] [Related]
2. Novel sequence variations in the brain-derived neurotrophic factor gene and association with major depression and antidepressant treatment response.
Licinio J; Dong C; Wong ML
Arch Gen Psychiatry; 2009 May; 66(5):488-97. PubMed ID: 19414708
[TBL] [Abstract][Full Text] [Related]
3. Suicidality scores during double-blind fluoxetine and desipramine treatment in Mexican Americans.
Sharma A; Busnello JV; Ribeiro L; Thakur S; Whelan F; Elashoff RM; Wong ML; Licinio J
J Clin Psychopharmacol; 2007 Feb; 27(1):99-101. PubMed ID: 17224728
[No Abstract] [Full Text] [Related]
4. Reboxetine, a new noradrenaline selective antidepressant, is at least as effective as fluoxetine in the treatment of depression.
Andreoli V; Caillard V; Deo RS; Rybakowski JK; Versiani M
J Clin Psychopharmacol; 2002 Aug; 22(4):393-9. PubMed ID: 12172339
[TBL] [Abstract][Full Text] [Related]
5. Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study.
Nelson JC; Mazure CM; Jatlow PI; Bowers MB; Price LH
Biol Psychiatry; 2004 Feb; 55(3):296-300. PubMed ID: 14744472
[TBL] [Abstract][Full Text] [Related]
6. Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans.
Licinio J; O'Kirwan F; Irizarry K; Merriman B; Thakur S; Jepson R; Lake S; Tantisira KG; Weiss ST; Wong ML
Mol Psychiatry; 2004 Dec; 9(12):1075-82. PubMed ID: 15365580
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of initial antidepressant drug choice in a "real world" randomized trial.
Simon GE; Heiligenstein J; Revicki D; VonKorff M; Katon WJ; Ludman E; Grothaus L; Wagner E
Arch Fam Med; 1999; 8(4):319-25. PubMed ID: 10418538
[TBL] [Abstract][Full Text] [Related]
8. Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial.
Goldstein DJ; Mallinckrodt C; Lu Y; Demitrack MA
J Clin Psychiatry; 2002 Mar; 63(3):225-31. PubMed ID: 11926722
[TBL] [Abstract][Full Text] [Related]
9. Association of a brain methylation site with clinical outcomes in depression does not replicate across populations.
Uher R; Ripke S; Müller-Myhsok B; Lewis CM; Perlis RH
Am J Psychiatry; 2015 Apr; 172(4):395-7. PubMed ID: 25827039
[No Abstract] [Full Text] [Related]
10. Do depressed subjects who have failed both fluoxetine and a tricyclic antidepressant respond to the combination?
Levitt AJ; Joffe RT; Kamil R; McIntyre R
J Clin Psychiatry; 1999 Sep; 60(9):613-6. PubMed ID: 10520980
[TBL] [Abstract][Full Text] [Related]
11. A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression.
Musselman DL; Somerset WI; Guo Y; Manatunga AK; Porter M; Penna S; Lewison B; Goodkin R; Lawson K; Lawson D; Evans DL; Nemeroff CB
J Clin Psychiatry; 2006 Feb; 67(2):288-96. PubMed ID: 16566626
[TBL] [Abstract][Full Text] [Related]
12. Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action.
Delgado PL; Miller HL; Salomon RM; Licinio J; Krystal JH; Moreno FA; Heninger GR; Charney DS
Biol Psychiatry; 1999 Jul; 46(2):212-20. PubMed ID: 10418696
[TBL] [Abstract][Full Text] [Related]
13. Association of brain-derived neurotrophic factor genetic Val66Met polymorphism with severity of depression, efficacy of fluoxetine and its side effects in Chinese major depressive patients.
Zou YF; Wang Y; Liu P; Feng XL; Wang BY; Zang TH; Yu X; Wei J; Liu ZC; Liu Y; Tao M; Li HC; Li KQ; Hu J; Li M; Zhang KR; Ye DQ; Xu XP
Neuropsychobiology; 2010; 61(2):71-8. PubMed ID: 20016225
[TBL] [Abstract][Full Text] [Related]
14. Rare Functional Variants Associated with Antidepressant Remission in Mexican-Americans: Short title: Antidepressant remission and pharmacogenetics in Mexican-Americans.
Wong ML; Arcos-Burgos M; Liu S; Licinio AW; Yu C; Chin EWM; Yao WD; Lu XY; Bornstein SR; Licinio J
J Affect Disord; 2021 Jan; 279():491-500. PubMed ID: 33128939
[TBL] [Abstract][Full Text] [Related]
15. [Response to serotonergic and noradrenergic antidepressants: a crossover study of fluoxetine and desipramine in patients with first major depression episode].
Ontiveros-Sánchez de la Barquera JA
Gac Med Mex; 2017; 153(6):688-694. PubMed ID: 29206826
[TBL] [Abstract][Full Text] [Related]
16. Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine.
Fava M; Alpert J; Nierenberg A; Lagomasino I; Sonawalla S; Tedlow J; Worthington J; Baer L; Rosenbaum JF
J Clin Psychopharmacol; 2002 Aug; 22(4):379-87. PubMed ID: 12172337
[TBL] [Abstract][Full Text] [Related]
17. Response to Uher et al.
Wong ML; Dong C; Flores DL; Ehrhart-Bornstein M; Bornstein S; Arcos-Burgos M; Licinio J
Am J Psychiatry; 2015 Apr; 172(4):396-8. PubMed ID: 25827040
[No Abstract] [Full Text] [Related]
18. Individualized homeopathic treatment and fluoxetine for moderate to severe depression in peri- and postmenopausal women (HOMDEP-MENOP study): a randomized, double-dummy, double-blind, placebo-controlled trial.
Macías-Cortés Edel C; Llanes-González L; Aguilar-Faisal L; Asbun-Bojalil J
PLoS One; 2015; 10(3):e0118440. PubMed ID: 25768800
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression.
Schatzberg A; Roose S
Am J Geriatr Psychiatry; 2006 Apr; 14(4):361-70. PubMed ID: 16582045
[TBL] [Abstract][Full Text] [Related]
20. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.
Davidson JR; Meoni P; Haudiquet V; Cantillon M; Hackett D
Depress Anxiety; 2002; 16(1):4-13. PubMed ID: 12203668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]